A1
Healthcare professionals
Prescriber-facing communication built inside your compliance framework: congress support, medical education assets, portal content and field-force enablement.
[ Pharmaceutical & life sciences marketing ]
Marketing for a category where accuracy is the brand.
Triadic builds corporate digital presence, scientific content support, trade communication and recruitment campaigns for pharmaceutical, nutraceutical and healthtech companies — governed by your regulatory and medical review process, not by what a campaign wishes it could claim.
Corporate digitalScientific contentTrade & distributionDisease awarenessEmployer brandingTechnical SEO
fig.01 — engagement model
- INPUTApproved product information, published data
- REVIEWRegulatory & medical affairs sign-off
- OUTPUTCorporate, educational and trade channels
How we work in a regulated category
We do not author clinical claims and we do not make efficacy or safety statements. Where a claim is needed it comes from your approved product information or published data supplied by your medical team, and it is reproduced exactly and referenced. Product promotion is subject to your internal regulatory and medical review, and to the rules of each market you operate in. Our role is structure, clarity, distribution and governance.
[ 01 ] Audience architecture
Four audiences, four sets of rules.
Pharmaceutical communication fails when everything is pushed through one channel and one tone. We separate the audiences first, then decide what can be said to each.
A2
Trade, pharmacy & distribution
The commercial layer that is usually neglected — distributor communication, pharmacy-facing material, channel campaigns and order-side digital tooling.
A3
Patients & the public
Disease-awareness and health-literacy content authored with your medical team, kept strictly educational and free of product promotion where regulation requires it.
A4
Corporate & talent
Investor-facing corporate presence, ESG and quality narratives, LinkedIn strategy, and recruitment marketing for scientific and commercial roles.
[ 02 ] Process
Review is designed in, not bolted on.
The most expensive thing in regulated marketing is finished work that cannot be approved. Our sequence front-loads the constraints so production only ever builds what can actually go live.
P-01
Discovery & constraint mapping
We document what you can say, to whom, in which market, and who signs it off — before any creative work begins.
P-02
Architecture
Information architecture, audience gating where required, and a content model that separates corporate, educational and promotional material.
P-03
Production under review
Concept-stage review, then build. Claims sourced from approved product information, referenced and version-controlled.
P-04
Distribution
Technical SEO, LinkedIn, trade channels and — where permitted and appropriate — paid placement with policy-compliant targeting.
P-05
Measurement & maintenance
Reporting against reach, engagement quality and recruitment or trade outcomes, plus scheduled content review so nothing goes stale or out of date.
[ 03 ] Capability index
What we are typically engaged for.
C-01
Corporate website & digital infrastructure
Architecture, build, accessibility, performance, multi-market structure
C-02
Scientific & medical content support
Editorial structure, referencing discipline, plain-language versions
C-03
Technical & organic SEO
Crawlability, schema, corporate authority, multilingual considerations
C-04
LinkedIn & corporate social
Leadership positioning, company channel, employee advocacy
C-05
Trade & distributor communication
Channel assets, pharmacy-facing material, order-side tooling
C-06
Recruitment & employer brand
Careers experience, role campaigns, scientific talent attraction
C-07
Disease awareness programmes
Educational content co-authored with medical teams
C-08
Governance & reporting
Approval trails, version control, scheduled content review
[ 04 ] Digital credibility
Search engines and regulators want the same thing.
Health and medical content is held to a higher bar by search engines than almost any other category — attribution, expertise, accuracy and currency. That standard maps closely onto what a compliance function already asks for, which is why doing the regulated thing properly tends to improve organic performance rather than restrict it.
We build the corporate estate so both audiences — human reviewers and search crawlers — can see exactly who wrote what, on what basis, and when it was last checked.
Technical SEO- 01Named authors and reviewers on substantive content
- 02Every claim traceable to approved product information or published data
- 03Clear separation of corporate, educational and promotional material
- 04Accessible, fast, standards-compliant front-end delivery
- 05Structured data so search engines can read your corporate entity correctly
- 06Scheduled review dates so published content does not silently expire
Markets
Pakistan-wide corporate and trade work, with campaign experience across the Gulf.
Base
Islamabad studio, serving Islamabad, Rawalpindi and the twin-city corridor.
Adjacent experience
Laboratory and clinical services work, including Metropole Laboratories.
[ 05 ] Related
Across the healthcare estate.
Pharmaceutical work frequently sits alongside provider-side marketing. These pages cover the clinical and practice models we also support.
Doctors, therapists & private practices
ExploreHealthcare Marketing
Patient acquisition systems built for clinics, specialists and US private practices.
Medical aesthetics & skin clinics
ExploreAesthetic Clinic Marketing
Clinical credibility plus premium positioning for treatment-led clinics.
Developers, agencies & project launches
ExploreReal Estate Marketing
Listing visibility, launch campaigns and qualified buyer pipelines.
[ 06 ] FAQ
Questions from compliance and commercial teams.
Yes, within clear limits. A great deal of pharmaceutical communication is corporate rather than promotional: company positioning, manufacturing and quality narratives, distribution and trade communication, recruitment and employer branding, disease-awareness education, and digital infrastructure. Product promotion that targets prescribers or the public is tightly governed, and that work belongs inside your regulatory and medical affairs review process — we build to it rather than around it.
Review-first. Nothing that touches a product claim goes live without sign-off from your regulatory or medical affairs contact, and we structure production so review happens at concept stage rather than after assets are finished. We keep a version trail of what was approved, by whom and when, so an audit request is a filing exercise rather than an investigation.
No. We do not author clinical claims. Where a claim is required, it comes from your approved product information or published data supplied by your medical team, and it is reproduced exactly. Our writing job is clarity and structure, not scientific interpretation.
A significant amount. Corporate website and investor-facing content, manufacturing and quality storytelling, distributor and pharmacy trade communication, recruitment marketing for scientific and commercial roles, corporate social presence on LinkedIn, disease-awareness content built with your medical team, and the technical SEO that makes all of it findable.
Yes, and those categories usually have more promotional latitude than prescription medicines — though claims rules still apply and vary by market. We treat the substantiation standard as the starting point of the brief rather than something to test the limits of.
Triadic is based in Islamabad and works with clients across Islamabad, Rawalpindi and the wider Pakistani market, as well as in the Gulf. In the adjacent healthcare space we have worked with laboratory and clinical services businesses, including Metropole Laboratories.
[ next ]
Start with the constraints. The strategy follows.
Tell us your markets, your review process and what you are trying to achieve this year. We will map what is possible inside those limits before anyone writes a proposal.